Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy

Archive ouverte

Krochmal, Magdalena | Kontostathi, Georgia | Magalhães, Pedro | Makridakis, Manousos | Klein, Julie | Husi, Holger | Leierer, Johannes | Mayer, Gert | Bascands, Jean-Loup | Denis, Colette | Zoidakis, Jerome | Zürbig, Petra | Delles, Christian | Schanstra, Joost P | Mischak, Harald | Vlahou, Antonia

Edité par CCSD ; Nature Publishing Group -

Mechanisms underlying the onset and progression of nephropathy in diabetic patients are not fully elucidated. Deregulation of proteolytic systems is a known path leading to disease manifestation, therefore we hypothesized that proteases aberrantly expressed in diabetic nephropathy (DN) may be involved in the generation of DN-associated peptides in urine. We compared urinary peptide profiles of DN patients (macroalbuminuric, n = 121) to diabetic patients with no evidence of DN (normoalbuminuric, n = 118). 302 sequenced, differentially expressed peptides (adjusted p-value < 0.05) were analysed with the Proteasix tool predicting proteases potentially involved in their generation. Activity change was estimated based on the change in abundance of the investigated peptides. Predictions were correlated with transcriptomics (Nephroseq) and relevant protein expression data from the literature. This analysis yielded seventeen proteases, including multiple forms of MMPs, cathepsin D and K, kallikrein 4 and proprotein convertases. The activity of MMP-2 and MMP-9, predicted to be decreased in DN, was investigated using zymography in a DN mouse model confirming the predictions. Collectively, this proof-of-concept study links urine peptidomics to molecular changes at the tissue level, building hypotheses for further investigation in DN and providing a workflow with potential applications to other diseases.

Suggestions

Du même auteur

Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment

Archive ouverte | P. Schanstra, Joost | CCSD

International audience. Although cardiovascular disease (CVD) is the leading cause of morbimortality worldwide, promising new drug candidates are lacking. We compared the arterial high-resolution proteome of patient...

Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease

Archive ouverte | Mokou, Marika | CCSD

International audience. The increased prevalence of cardiovascular disease (CVD) indicates a demand for novel therapeutic approaches. Proteome analysis of vascular tissues from animal models and humans with CVD coul...

Connectivity mapping of glomerular proteins identifies dimethylaminoparthenolide as a new inhibitor of diabetic kidney disease

Archive ouverte | Klein, Julie | CCSD

International audience. Abstract While blocking the renin angiotensin aldosterone system (RAAS) has been the main therapeutic strategy to control diabetic kidney disease (DKD) for many years, 25–30% of diabetic pati...

Chargement des enrichissements...